Vericel Corp. said Wednesday that the U.S. Food and Drug Administration or FDA has approved Maci for the repair of symptomatic, full-thickness cartilage defects of the knee in adult patients. Shares of Vericel are surging more than 55 percent following the news.
from RTT - Biotech http://ift.tt/2gADdqU
via IFTTT
No comments:
Post a Comment